Filing Details
- Accession Number:
- 0001127602-25-007615
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 08:41:49
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 08:41:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Labcorp Holdings Inc. | LH | Services-Medical Laboratories (8071) | 992588107 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1793112 | S Mark Schroeder | 531 South Spring Street Burlington NC 27215 | Evp, Pres Diagnostics & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-28 | 3,903 | $131.43 | 10,299 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-28 | 5,339 | $249.23 | 4,960 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2025-02-28 | 3,903 | $0.00 | 3,903 | $131.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-02-12 | 2029-02-11 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- The options vested in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
